Functional TNFα gene silencing mediated by polyethyleneimine/TNFα siRNA nanocomplexes in inflamed colon.
about
Nanomedicine and drug delivery strategies for treatment of inflammatory bowel diseaseRNA interference-based nanosystems for inflammatory bowel disease therapyProgress toward in vivo use of siRNAs-IIGenetic deletion of Klf4 in the mouse intestinal epithelium ameliorates dextran sodium sulfate-induced colitis by modulating the NF-κB pathway inflammatory responseChitosan hydrogel as siRNA vector for prolonged gene silencing.Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colonNanomedicine in GINew strategies for treatment of inflammatory bowel diseaseCurcumin Nanoparticles Attenuate Production of Pro-inflammatory Markers in Lipopolysaccharide-Induced Macrophages.Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophagesHyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.A(₂B)AR expression in non-immune cells plays an important role in the development of murine colitisCo-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy.Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.Nanomedicines for Endothelial Disorders.Plant derived edible nanoparticles as a new therapeutic approach against diseases.Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapyCombination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.Cytokine blockade in inflammatory bowel diseases.Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease.Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders.Polyethylenimines for siRNA and miRNA delivery in vivo.Multifunctional nanoparticles for targeting cancer and inflammatory diseases.Therapeutic gene delivery using bioreducible polymers.Nanotechnology in the treatment of inflammatory bowel diseases.Targeted delivery systems for biological therapies of inflammatory diseases.Effect of interleukin-1β and tumor necrosis factor α gene silencing on mouse gastric cancer cell proliferation and migration.Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.A click-and-release approach to CO prodrugs.Fab'-bearing siRNA TNFα-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis.Nanomedicines for dysfunctional macrophage-associated diseases.Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnologySupramolecular self-assembled nanoparticles mediate oral delivery of therapeutic TNF-α siRNA against systemic inflammation.Polymer-based drug delivery: the quest for local targeting of inflamed intestinal mucosa.Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancerPotential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases.Dexamethasone-loaded Polymeric Nanoconstructs for Monitoring and Treating Inflammatory Bowel Disease.Thermo-sensitive nanoparticles for triggered release of siRNA.Oral delivery of curcumin via porous polymeric nanoparticles for effective ulcerative colitis therapy.
P2860
Q26777400-F6C8A00E-4DDC-4B1E-9777-658C0FDB5101Q28071518-42C320F0-890B-4F77-9C98-2B3F2CD07776Q28255877-A5C1A4E2-8797-4A07-AF03-F77F7E219B91Q33881932-90037008-A632-4D62-9CDD-C544305170C6Q33925196-A7E7D2CC-186F-4000-AA58-E242158B98FFQ34199709-DFB4E7A6-39E0-45BB-89BC-F55884871CCFQ34719056-48469C0F-CCAF-4CCC-BC5A-CC4618291FD2Q35069777-C430D45E-6C57-424B-851F-741845180424Q35767179-A2E39E58-3C87-4B9C-BE1A-56D69E855844Q36166289-B2DE11D6-5384-4E29-9500-F0D44E389669Q36201940-CF8345AD-0B6D-44C0-8CF6-50C4E4CA9165Q36218394-8968DAD1-8643-437B-AD70-BEC8437CBE25Q36326103-3E624E96-5E36-44B5-AE7B-F04416A9F74EQ36414624-27C4ADD5-6DCA-408A-B3A1-1230BA3903E4Q36651592-DE08EAEA-C355-4A0B-9522-7D9C4FC637B2Q37012929-2ADAC0A9-B05B-42E9-90D3-61272377CE4AQ37146028-1C587EB0-C2EC-4791-8E12-85EB2AAECB65Q37469872-3597F308-7F86-42F7-B2EF-A0CD6F06A90BQ37690479-9071C3BB-2E73-4675-8755-79C26DCB83AFQ37952792-5C60A49E-8CFD-4F8D-8E92-1A543C192336Q38049367-D0FB6FE2-C520-4C3B-B373-CFB252E78C46Q38105404-BCD80851-C293-45F0-8F69-E0F803F1642CQ38110474-08E67813-C88C-4F92-B748-743BF5C5C033Q38136253-9B1A14BA-D12A-448A-9199-F9D9CABD830BQ38157750-F3B40DEF-AF0D-49C9-A98C-D6AE37806EEAQ38200842-1F84D1B1-A8C6-4E47-BC99-4E88A31121ADQ38264691-C30BEA0B-4F9F-4534-8D03-BB77F97F77C7Q38778609-EA092EBE-CBA7-4C80-9003-4784CDA8309CQ38834450-5A6DCA08-E808-439F-9FB4-8D77B04F09B7Q38942209-AF75EFA8-1CB7-44A1-8F3A-16BD912B5F96Q38997094-A37816D3-9629-4B07-AA4E-7C06497F8827Q39069052-020A024B-6B9D-470E-9CB3-7B93F1D1CDE9Q39076103-53A11EF2-FBAF-4988-A5FA-E876DD3531E3Q39162056-568C5BAE-D539-4D1F-BA8D-80788A4F7E6DQ39170844-7A097FA5-03BA-4184-A29B-7AA58EC85519Q42176588-423A2CA0-BCD4-4E96-A448-EA09DD3CDBC5Q43202907-5E6D4990-B8C4-40D8-8E5F-955889E3C959Q43652013-6848A2AD-25D8-4826-BABC-70E3B2A9A9C8Q45871840-A4F25B58-7564-436D-B46F-76483C26CB3EQ46272530-FF6C68E1-0E72-4899-811A-B8CF9E8F0C93
P2860
Functional TNFα gene silencing mediated by polyethyleneimine/TNFα siRNA nanocomplexes in inflamed colon.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Functional TNFα gene silencing ...... nocomplexes in inflamed colon.
@ast
Functional TNFα gene silencing ...... nocomplexes in inflamed colon.
@en
Functional TNFα gene silencing ...... nocomplexes in inflamed colon.
@nl
type
label
Functional TNFα gene silencing ...... nocomplexes in inflamed colon.
@ast
Functional TNFα gene silencing ...... nocomplexes in inflamed colon.
@en
Functional TNFα gene silencing ...... nocomplexes in inflamed colon.
@nl
prefLabel
Functional TNFα gene silencing ...... nocomplexes in inflamed colon.
@ast
Functional TNFα gene silencing ...... nocomplexes in inflamed colon.
@en
Functional TNFα gene silencing ...... nocomplexes in inflamed colon.
@nl
P2093
P2860
P1433
P1476
Functional TNFα gene silencing ...... anocomplexes in inflamed colon
@en
P2093
Arianne L Theiss
Didier Merlin
Hamed Laroui
Hang T T Nguyen
Shanthi V Sitaraman
P2860
P304
P356
10.1016/J.BIOMATERIALS.2010.09.062
P577
2011-02-01T00:00:00Z